: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

COVID-19: Daily Top 10 Papers

Colorectal Neoplasms

Free Subscription

Articles published in Anticancer Res
Retrieve available abstracts of 334 articles:
HTML format

Single Articles

April 2021

NIISATO Y, Moriwaki T, Fukuoka S, Masuishi T, et al
Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib Treatment.
Anticancer Res. 2021;41:2203-2207.
PubMed Abstract available

ISHIZAKI T, Mazaki J, Enomoto M, Shigoka M, et al
Prospective Multicenter Phase II Study of Biweekly TAS-102 and Bevacizumab for Metastatic Colorectal Cancer.
Anticancer Res. 2021;41:2157-2163.
PubMed Abstract available

WATANABE T, Shiozawa M, Kimura Y, Hiroshima Y, et al
Clinical Significance of Stanniocalcin2 mRNA Expression in Patients With Colorectal Cancer.
Anticancer Res. 2021;41:2117-2122.
PubMed Abstract available

SHIBA S, Shibuya K, Okamoto M, Okano N, et al
Carbon-ion Radiotherapy for Oligometastatic Colorectal Cancer in the Liver or Lung.
Anticancer Res. 2021;41:1997-2005.
PubMed Abstract available

NISHINO H, Okuno M, Seo S, Toda R, et al
Sinusoidal Obstruction Syndrome Promotes Liver Metastatic Seeding of Colorectal Cancer Cells in a Rat Model.
Anticancer Res. 2021;41:1803-1810.
PubMed Abstract available

MAEDA T, Konishi H, Takaki W, Takabatake K, et al
Significance of Plasma UCA1 for Predicting Colorectal Cancer and BRAF Mutation Status.
Anticancer Res. 2021;41:1761-1769.
PubMed Abstract available

March 2021

SHIBUTANI M, En W, Okazaki Y, Maeda K, et al
A High Postoperative Serum C-reactive Protein Level Has a Negative Impact on Long-term Survival, Regardless of Postoperative Infectious Complications, in Patients Who Undergo Laparoscopic Surgery for Colorectal Cancer.
Anticancer Res. 2021;41:1593-1598.
PubMed Abstract available

PACZEK S, Lukaszewicz-Zajac M, Gryko M, Kulczynska-Przybik A, et al
The Clinical Utility of Serum CXCR-2 Assessment in Colorectal Cancer (CRC) Patients.
Anticancer Res. 2021;41:1421-1428.
PubMed Abstract available

MO S, Ku HJ, Choi SH, Jeong HJ, et al
470 nm LED Irradiation Inhibits the Invasiveness of CD133-positive Human Colorectal Cancer Stem Cells by Suppressing the Cyclooxygenase-2/prostaglandin E2 Pathway.
Anticancer Res. 2021;41:1407-1420.
PubMed Abstract available

TERASAKI M, Hamoya T, Kubota A, Kojima H, et al
Fucoxanthin Prevents Colorectal Cancer Development in Dextran Sodium Sulfate-treated Apc (Min/+) Mice.
Anticancer Res. 2021;41:1299-1305.
PubMed Abstract available

ASADA Y, Tsuruta M, Okabayashi K, Shigeta K, et al
Inhibition of Heat-shock Protein 27 Reduces 5-Fluorouracil-acquired Resistance in Human Colon Cancer Cells.
Anticancer Res. 2021;41:1283-1290.
PubMed Abstract available

WANG S, Wang X, Wang YU, Leng Q, et al
The Anti-oxidant Monoterpene p-Cymene Reduced the Occurrence of Colorectal Cancer in a Hyperlipidemia Rat Model by Reducing Oxidative Stress and Expression of Inflammatory Cytokines.
Anticancer Res. 2021;41:1213-1218.
PubMed Abstract available

AGAWA K, Matsuda T, Yamashita K, Hasegawa H, et al
Feasibility and Safety of Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiotherapy for Elderly Patients With Locally Advanced Rectal Cancer.
Anticancer Res. 2021;41:1677-1682.
PubMed Abstract available

HIROSE Y, Sakata J, Kobayashi T, Miura K, et al
NQO1 as a Marker of Chemosensitivity and Prognosis for Colorectal Liver Metastasis.
Anticancer Res. 2021;41:1563-1570.
PubMed Abstract available

RUBIO CA, Schmidt PT
Nondysplastic Crypts in Fission in Nonpolypoid Adenomas and in the Adjacent Mucosa Support Field Cancerization in the Colon.
Anticancer Res. 2021;41:1515-1521.
PubMed Abstract available

February 2021

PIAN G, Shin JS, Yoon S, Oh SY, et al
Prognostic Reappraisal of Postoperative Carcinoembryonic Antigen in T1-2N0 Colorectal Cancer.
Anticancer Res. 2021;41:1101-1110.
PubMed Abstract available

KOSUMI K, Mima K, Morito A, Yumoto S, et al
Patient Age and Long-term Survival in Colorectal Cancer Patients Who Undergo Emergency Surgery.
Anticancer Res. 2021;41:1069-1076.
PubMed Abstract available

NAKASHIMA M, Takeuchi M, Tanaka S, Kawakami K, et al
Salvage Therapy After Regorafenib or Trifluridine/Tipiracil Treatment of Metastatic Colorectal Cancer: A Conditional Landmark Analysis.
Anticancer Res. 2021;41:1055-1062.
PubMed Abstract available

OBARA N, Hirano Y, Ishii T, Kondo H, et al
Laparoscopic Surgery for Colorectal Cancer in Patients on Hemodialysis: A Propensity Score-matched Analysis.
Anticancer Res. 2021;41:993-997.
PubMed Abstract available

NAKAMURA M, Kageyama SI, Seki M, Suzuki A, et al
Liquid Biopsy Cell-free DNA Biomarkers in Patients With Oligometastatic Colorectal Cancer Treated by Ablative Radiotherapy.
Anticancer Res. 2021;41:829-834.
PubMed Abstract available

PAPADIMITRIOU M, Papadimitriou CA
Antiangiogenic Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: Focusing on Regorafenib.
Anticancer Res. 2021;41:567-582.
PubMed Abstract available

January 2021

HUANG RH, Yang WK, Wu CM, Yeh CM, et al
Over-expression of CEP55 Predicts Favorable Prognosis in Colorectal Cancer Patients With Lymph Node Involvement.
Anticancer Res. 2021;41:543-547.
PubMed Abstract available

YAMADA Y, Matsuhashi N, Fujii H, Makiyama A, et al
Impact of Anti-angiogenic Agents on Chemotherapy Efficacy in Patients With Metastatic Colorectal Cancer: Second-line FOLFIRI Plus Bevacizumab or Aflibercept.
Anticancer Res. 2021;41:533-541.
PubMed Abstract available

PODGORSKA M, Pietraszek-Gremplewicz K, OlszaNska J, Nowak D, et al
The Role of Apelin and Apelin Receptor Expression in Migration and Invasiveness of Colon Cancer Cells.
Anticancer Res. 2021;41:151-161.
PubMed Abstract available

THADI A, Morano WF, Khalili M, Babcock BD, et al
Molecular Targeting of H/MDM-2 Oncoprotein in Human Colon Cancer Cells and Stem-like Colonic Epithelial-derived Progenitor Cells.
Anticancer Res. 2021;41:27-42.
PubMed Abstract available

SCHEIPNER L, Smolle MA, Barth D, Posch F, et al
The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal Carcinoma.
Anticancer Res. 2021;41:429-436.
PubMed Abstract available

December 2020

KIMURA M, Usami E, Yoshimura T
Effects of Type of Antibody to EGFR and Hypomagnesemia on Overall Survival in First-line Treatment of Patients With Unresectable Advanced/Recurrent Colorectal Cancer.
Anticancer Res. 2020;40:7135-7140.
PubMed Abstract available

AHMED A, Halama N
Differential Analyses of Peripheral Blood Parameters in CCR5 Inhibition-treated Colorectal Cancer Patients Reveal Dynamic Changes Linked to Clinical Outcomes.
Anticancer Res. 2020;40:6933-6939.
PubMed Abstract available

ANNICCHIARICO A, Morini A, Romboli A, RiccO M, et al
Stage III and Metastatic Lymph Node Ratio Are the only Independent Prognostic Factors in Colorectal Signet-ring Cell Carcinoma Patients.
Anticancer Res. 2020;40:7127-7134.
PubMed Abstract available

LIU B, Shiraga S, Mortenson MM, Lai J, et al
Small Cell Lung Carcinoma and Synchronous Rectal Adenocarcinoma and Jejunal Gastrointestinal Stromal Tumor Present in a Patient With History of Laryngeal Squamous Cell Carcinoma.
Anticancer Res. 2020;40:7053-7056.
PubMed Abstract available

VODICKA J, Fichtl J, Sebek J, ProchAzkovA K, et al
Outcomes and Prognostic Factors Following Surgical Treatment of Pulmonary Metastases from Colorectal Carcinoma.
Anticancer Res. 2020;40:7045-7051.
PubMed Abstract available

YAMAMOTO J, Sugisawa N, Hamada K, Nishino H, et al
A Universal Gelfoam 3-D Histoculture Method to Establish Patient-derived Cancer Cells (3D-PDCC) Without Fibroblasts from Patient-derived Xenografts.
Anticancer Res. 2020;40:6765-6768.
PubMed Abstract available

PALEK R, Rosendorf J, Maleckova A, Vistejnova L, et al
Influence of Mesenchymal Stem Cell Administration on The Outcome of Partial Liver Resection in a Porcine Model of Sinusoidal Obstruction Syndrome.
Anticancer Res. 2020;40:6817-6833.
PubMed Abstract available

November 2020

AHMED A, Halama N
Tertiary Lymphoid Structures in Colorectal Cancer Liver Metastases: Association With Immunological and Clinical Parameters and Chemotherapy Response.
Anticancer Res. 2020;40:6367-6373.
PubMed Abstract available

NGAMKHAM J, Thuwajit C, Thuwajit P, Khamwachirapithak P, et al
Overexpression of Pyruvate Carboxylase Is Correlated With Colorectal Cancer Progression and Supports Growth of Invasive Colon Cancer HT-29 Cell Line.
Anticancer Res. 2020;40:6285-6293.
PubMed Abstract available

LIN PM, Lee HM, Huang CI, Tai TS, et al
Synergistic Antiproliferative Effect of Ribociclib (LEE011) and 5-Fluorouracil on Human Colorectal Cancer.
Anticancer Res. 2020;40:6265-6271.
PubMed Abstract available

MUSA M, Ouaret D, Bodmer WF
In Vitro Analyses of Interactions Between Colonic Myofibroblasts and Colorectal Cancer Cells for Anticancer Study.
Anticancer Res. 2020;40:6063-6073.
PubMed Abstract available

NAGATA M, Matsuda T, Hasegawa H, Utsumi M, et al
Usefulness of Omentoplasty to Reduce Perineal Wound Complications in Abdominoperineal Resection After Neoadjuvant Chemoradiotherapy.
Anticancer Res. 2020;40:6539-6543.
PubMed Abstract available

RYU S, Okamoto A, Nakashima K, Hara K, et al
Usefulness of Preoperative Endoscopic Fluorescent Clip Marking in Laparoscopic Gastrointestinal Surgery.
Anticancer Res. 2020;40:6517-6523.
PubMed Abstract available

HUANG WL, Luo CW, Chou CL, Yang CC, et al
High Expression of UBE2B as a Poor Prognosis Factor in Patients With Rectal Cancer Following Chemoradiotherapy.
Anticancer Res. 2020;40:6305-6317.
PubMed Abstract available

October 2020

GO G, Yun CW, Yoon YM, Lim JH, et al
Role of PrP(C) in Cancer Stem Cell Characteristics and Drug Resistance in Colon Cancer Cells.
Anticancer Res. 2020;40:5611-5620.
PubMed Abstract available

YAMADA Y, Yoshimatsu K, Yokomizo H, Okayama S, et al
Expression of ATP-binding Cassette Transporter 11 (ABCC11) Protein in Colon Cancer.
Anticancer Res. 2020;40:5405-5409.
PubMed Abstract available

JONSSON G, Philipson L, Villman K, Valachis A, et al
Upfront Radiotherapy in Patients With Asymptomatic Incurable Rectal Cancer: A Retrospective Cohort Study.
Anticancer Res. 2020;40:5853-5860.
PubMed Abstract available

ANGELOU A, Papalois AE, Antoniou E, Wang J, et al
The Interplay Between Innate Immunity (TLR-4) and sCD40L in the Context of an Animal Model of Colitis-associated Cancer.
Anticancer Res. 2020;40:5457-5462.
PubMed Abstract available

YIN F, Xie H, Lai J, Chen Y, et al
Double Negativity for Expression of YAP1 and CDX2 Defines an Aggressive Type of Colitis-associated Cancer.
Anticancer Res. 2020;40:5411-5416.
PubMed Abstract available

JIA JB, Ling X, Xing M, Ludwig JM, et al
Novel TSPO-targeted Doxorubicin Prodrug for Colorectal Carcinoma Cells.
Anticancer Res. 2020;40:5371-5378.
PubMed Abstract available

September 2020

TAKAHASHI H, Takeda T, Nishizawa Y, Ogino T, et al
Phase I Study of the Administration of Low-dose Perioperative Human Atrial Natriuretic Peptide in Patients With Resectable Colorectal Cancer.
Anticancer Res. 2020;40:5301-5307.
PubMed Abstract available

NIKOLOVA B, Semkova S, Tsoneva I, Stoyanova E, et al
Redox-related Molecular Mechanism of Sensitizing Colon Cancer Cells to Camptothecin Analog SN38.
Anticancer Res. 2020;40:5159-5170.
PubMed Abstract available

MOZOLEWSKA P, Duzowska K, Pakiet A, Mika A, et al
Inhibitors of Fatty Acid Synthesis and Oxidation as Potential Anticancer Agents in Colorectal Cancer Treatment.
Anticancer Res. 2020;40:4843-4856.
PubMed Abstract available

August 2020

YAMADA T, Yoshida Y, Maeda T, Yoshimatsu G, et al
Changes in Immunological Status in Patients With Metastatic Colorectal Cancer Treated With First-line Chemoimmunotherapy.
Anticancer Res. 2020;40:4763-4771.
PubMed Abstract available

NISHI K, Tsunoda T, Uchida Y, Sueta T, et al
MK615 Suppresses Hypoxia Tolerance by Up-regulation of E-cadherin in Colorectal Cancer Cells With Mutant KRAS.
Anticancer Res. 2020;40:4687-4694.
PubMed Abstract available

KUWATA GO, Ikeda K, Manome Y
Involvement of Corticotropin-releasing Hormone-related Peptides in Cellular Stress Caused by Anticancer Drugs in Colorectal Cancer.
Anticancer Res. 2020;40:4505-4511.
PubMed Abstract available

KIM BH, Oh HK, Kim DW, Kang SB, et al
Clinical Implications of Cancer Stem Cell Markers and ABC Transporters as a Predictor of Prognosis in Colorectal Cancer Patients.
Anticancer Res. 2020;40:4481-4489.
PubMed Abstract available

CHIKATANI K, Chika N, Suzuki O, Sakimoto T, et al
A Model for Predicting DNA Mismatch Repair-deficient Colorectal Cancer.
Anticancer Res. 2020;40:4379-4385.
PubMed Abstract available

WANG L, Hirano Y, Heng G, Ishii T, et al
Better Cancer-specific Survival in Younger Patients With Stage III Colorectal Cancer: A Propensity Score Matching Study From Japan.
Anticancer Res. 2020;40:4365-4372.
PubMed Abstract available

KEIKES L, Koopman M, Lemmens VEPP, VAN Oijen MGH, et al
Practice Variation in the Adjuvant Treatment of Colon Cancer in the Netherlands: A Population-based Study.
Anticancer Res. 2020;40:4331-4341.
PubMed Abstract available

RAMOS-ESQUIVEL A, Chinchilla R, Valle M
Association of C677T and A1298C MTHFR Polymorphisms and Fluoropyrimidine-induced Toxicity in Mestizo Patients With Metastatic Colorectal Cancer.
Anticancer Res. 2020;40:4263-4270.
PubMed Abstract available

NISHI K, Ishikura S, Umebayashi M, Morisaki T, et al
Mutant KRAS Promotes NKG2D(+) T Cell Infiltration and CD155 Dependent Immune Evasion.
Anticancer Res. 2020;40:4663-4674.
PubMed Abstract available

FIORI E, Crocetti D, Lamazza A, DE Felice F, et al
Is Low Inferior Mesenteric Artery Ligation Worthwhile to Prevent Urinary and Sexual Dysfunction After Total Mesorectal Excision for Rectal Cancer?
Anticancer Res. 2020;40:4223-4228.
PubMed Abstract available

July 2020

SHIBUTANI M, Nagahara H, Fukuoka T, Iseki Y, et al
Combining Bevacizumab With Trifluridine/Thymidine Phosphorylase Inhibitor Improves the Survival Outcomes Regardless of the Usage History of Bevacizumab in Front-line Treatment of Patients With Metastatic Colorectal Cancer.
Anticancer Res. 2020;40:4157-4163.
PubMed Abstract available

POLITO R, Nigro E, Fei L, DE Magistris L, et al
Adiponectin Is Inversely Associated With Tumour Grade in Colorectal Cancer Patients.
Anticancer Res. 2020;40:3751-3757.
PubMed Abstract available

ENEH S, Heikkinen S, Hartikainen JM, Kuopio T, et al
MicroRNAs Associated With Biological Pathways of Left- and Right-sided Colorectal Cancer.
Anticancer Res. 2020;40:3713-3722.
PubMed Abstract available

MEKLIN J, SyrjAnen K, Eskelinen M
Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests.
Anticancer Res. 2020;40:3591-3604.
PubMed Abstract available

IGUCHI T, Sugimachi K, Mano Y, Motomura T, et al
Prognostic Impact of Geriatric Nutritional Risk Index in Patients With Synchronous Colorectal Liver Metastasis.
Anticancer Res. 2020;40:4165-4171.
PubMed Abstract available

VIRGILIO E, Montali F, Costi R, Cavallini M, et al
Proposal of a Classification System for Adenocarcinoma Involving the Ileocecal Valve (Bauhin's Valve): A Retrospective Study of 689 Right Hemicolectomized Patients.
Anticancer Res. 2020;40:4053-4057.
PubMed Abstract available

CAO C, Parikh P, Moezardalan K, Anantharaman A, et al
Synchronous Primary Pancreatic Ductal Carcinoma and Colonic Adenocarcinoma Present in a Patient With History of Skin Squamous Cell Carcinoma.
Anticancer Res. 2020;40:4029-4032.
PubMed Abstract available

June 2020

SHIBUTANI M, Nakao S, Maeda K, Nagahara H, et al
Inflammation Caused by Surgical Stress Has a Negative Impact on the Long-term Survival Outcomes in Patients With Colorectal Cancer.
Anticancer Res. 2020;40:3535-3542.
PubMed Abstract available

MATSUDA A, Yamada T, Jamjittrong S, Shinji S, et al
Comparison Between Biweekly and Weekly Cetuximab in Patients With Metastatic Colorectal Cancer: A Meta-analysis.
Anticancer Res. 2020;40:3469-3476.
PubMed Abstract available

BAE KB, Kim SH, Kang MS, Kim DH, et al
An Animal Model of Colorectal Cancer Liver Metastasis With a High Metastasis Rate and Clonal Dynamics.
Anticancer Res. 2020;40:3297-3306.
PubMed Abstract available

TABCHOURI N, Eid Y, Manceau G, Frontali A, et al
Neoadjuvant Treatment in Upper Rectal Cancer Does Not Improve Oncologic Outcomes But Increases Postoperative Morbidity.
Anticancer Res. 2020;40:3579-3587.
PubMed Abstract available

ETO K, Kosuge M, Ohkuma M, Ito D, et al
Umbilical Defunctioning Ileostomy for Rectal Cancer Results in Reduced Risk for Incisional Hernia.
Anticancer Res. 2020;40:3445-3451.
PubMed Abstract available

May 2020

FIORI E, Crocetti D, Lamazza A, DE Felice F, et al
Defecatory Dysfunction After Colon Cancer Resection: The Role of Inferior Mesenteric Artery Tie.
Anticancer Res. 2020;40:2969-2974.
PubMed Abstract available

ALMLOV K, Woisetschlager M, Loftas P, Hallbook O, et al
MRI Lymph Node Evaluation for Prediction of Metastases in Rectal Cancer.
Anticancer Res. 2020;40:2757-2763.
PubMed Abstract available

KOTNIK N, El-Sourani N, Raap U, Raab HR, et al
Expression of MicroRNA in Locoregional Recurrent Rectal Cancer.
Anticancer Res. 2020;40:2947-2953.
PubMed Abstract available

April 2020

WATANABE D, Fujii H, Matsuhashi N, Iihara H, et al
Dose Adjustment of Oxaliplatin Based on Renal Function in Patients With Metastatic Colorectal Cancer.
Anticancer Res. 2020;40:2379-2386.
PubMed Abstract available

ASHIZAWA N, Furuya S, Katsutoshi S, Sudo M, et al
Clinical Significance of Dynamic Neutrophil-lymphocyte Ratio Changes in Patients With Colorectal Cancer.
Anticancer Res. 2020;40:2311-2317.
PubMed Abstract available

HIGASHINO N, Matsuda T, Hasegawa H, Yamashita K, et al
Outcomes of Laparoscopic Surgery in Colorectal Cancer Patients With Dialysis.
Anticancer Res. 2020;40:2165-2170.
PubMed Abstract available

DE'ANGELIS N, Martinez-Perez A, Vitali GC, Pigneur F, et al
Predicting Difficult Laparoscopic Total Mesorectal Excision for Locally-advanced Mid-low Rectal Cancer: The EuMaRCS Score Validation.
Anticancer Res. 2020;40:2079-2087.
PubMed Abstract available

TOMORI K, Eto K, Haruki K, Sugano H, et al
Comparison of Strength of Anastomosis Between Four Different Techniques for Colorectal Surgery.
Anticancer Res. 2020;40:1891-1896.
PubMed Abstract available

NUMATA M, Kazama K, Onodera A, Hara K, et al
Short-term Outcomes Following Robotic-assisted Laparoscopic Surgery for Technically Demanding Rectal Cancer.
Anticancer Res. 2020;40:2337-2342.
PubMed Abstract available

HIRATA Y, Nozawa H, Kawai K, Hata K, et al
The Influence of Neoadjuvant Chemoradiation for Middle and Lower Rectal Cancer on Anorectal Function.
Anticancer Res. 2020;40:2199-2208.
PubMed Abstract available

KANG BH, Song C, Kang SB, Lee KW, et al
Nomogram for Predicting the Pathological Tumor Response from Pre-treatment Clinical Characteristics in Rectal Cancer.
Anticancer Res. 2020;40:2171-2177.
PubMed Abstract available

March 2020

KOJIMA T, Hino H, Shiomi A, Kagawa H, et al
Surgical Outcomes of Laparoscopic and Open D3 Dissection for Clinical Stage II/III Descending Colon Cancer.
Anticancer Res. 2020;40:1731-1737.
PubMed Abstract available

WANG L, Hirano Y, Heng G, Ishii T, et al
Mucinous Adenocarcinoma as a High-risk Factor in Stage II Colorectal Cancer: A Propensity Score-matched Study from Japan.
Anticancer Res. 2020;40:1651-1659.
PubMed Abstract available

KIMURA M, Usami E, Teramachi H, Yoshimura T, et al
Risk Benefit of FOLFIRI Plus Ramucirumab as Third-line and Later-line Treatment of Metastatic Colorectal Cancer.
Anticancer Res. 2020;40:1605-1611.
PubMed Abstract available

KIM HJ, Han YS, Lee JH, Lee SH, et al
Casein Kinase 2alpha Enhances 5-Fluorouracil Resistance in Colorectal Cancer Cells by Inhibiting Endoplasmic Reticulum Stress.
Anticancer Res. 2020;40:1419-1426.
PubMed Abstract available

SARHADI V, Lahti L, Saberi F, Youssef O, et al
Gut Microbiota and Host Gene Mutations in Colorectal Cancer Patients and Controls of Iranian and Finnish Origin.
Anticancer Res. 2020;40:1325-1334.
PubMed Abstract available

HUNG YC, Chang WS, Chou AK, Pei JS, et al
Association of Adiponectin Genotypes With Colorectal Cancer Susceptibility in Taiwan.
Anticancer Res. 2020;40:1297-1306.
PubMed Abstract available

HURLEY PJ, Bose N, Jha G, Gargano M, et al
Immunoglobulin Restores Immune Responses to BTH1677 in Patients With Low Levels of Antibodies to Beta-glucan.
Anticancer Res. 2020;40:1467-1473.
PubMed Abstract available

NAUMANN DN, Ain Q, Evans CFM, Bajwa A, et al
Factors Affecting Colorectal Polyp and Cancer Detection Rates in Patients Referred Urgently for Suspected Bowel Cancer.
Anticancer Res. 2020;40:1705-1709.
PubMed Abstract available

PALKOVICS A, Vereczkei A, Fincsur A, Kiss I, et al
Short- and Long-term Histological Changes in Liver Parenchyma After Different Resection Methods and Their Potential Role in Treatment of Colorectal Liver Metastasis.
Anticancer Res. 2020;40:1359-1365.
PubMed Abstract available

February 2020

YUN SH, Park JI
COUP-TFII Overexpression Inhibits Cell Proliferation and Invasion via Increased Expression of p53 and PTEN and Decreased Akt Phosphorylation in Human Colorectal Cancer SNU-C4 Cells.
Anticancer Res. 2020;40:767-777.
PubMed Abstract available

YUN SH, Park JI
PGC-1alpha Regulates Cell Proliferation and Invasion via AKT/GSK-3beta/beta-catenin Pathway in Human Colorectal Cancer SW620 and SW480 Cells.
Anticancer Res. 2020;40:653-664.
PubMed Abstract available

MEKLIN J, Syrjanen K, Eskelinen M
Colorectal Cancer Screening With Traditional and New-generation Fecal Immunochemical Tests: A Critical Review of Fecal Occult Blood Tests.
Anticancer Res. 2020;40:575-581.
PubMed Abstract available

NAKAMOTO T, Hokuto D, Nomi T, Yoshikawa T, et al
Characteristics of Five-year Survivors After Liver Resection for Colorectal Liver Metastases in Modern Chemotherapy.
Anticancer Res. 2020;40:1107-1116.
PubMed Abstract available

January 2020

RYU S, Suwa K, Kitagawa T, Aizawa M, et al
Evaluation of Anastomosis With ICG Fluorescence Method Using VISERA ELITE2 During Laparoscopic Colorectal Cancer Surgery.
Anticancer Res. 2020;40:373-377.
PubMed Abstract available

WATANABE D, Fujii H, Yamada Y, Iihara H, et al
Relationship Between Renal Function and the Incidence of Adverse Events in Patients With Colorectal Cancer Receiving Oxaliplatin.
Anticancer Res. 2020;40:299-304.
PubMed Abstract available

HAUS R, Janssen S, Schild SE, Rades D, et al
A Disease-specific Score for Estimating Survival After Irradiation of Bone Metastases from Colorectal Cancer.
Anticancer Res. 2020;40:287-291.
PubMed Abstract available

HIRABAYASHI S, Hayashi M, Nakayama G, Mii S, et al
The Significance of Molecular Biomarkers on Clinical Survival Outcome Differs Depending on Colon Cancer Sidedness.
Anticancer Res. 2020;40:201-211.
PubMed Abstract available

YUN SH, Han SH, Park JI
COUP-TFII Knock-down Promotes Proliferation and Invasion in Colorectal Cancer Cells via Activation of Akt Pathway and Up-regulation of FOXC1.
Anticancer Res. 2020;40:177-190.
PubMed Abstract available

TANAKA T, Kobunai T, Yamamoto Y, Murono K, et al
Assessment of the Changes in Mitochondrial Gene Polymorphism in Ulcerative Colitis and the Etiology of Ulcerative Colitis-associated Colorectal Cancer.
Anticancer Res. 2020;40:101-107.
PubMed Abstract available

OKUYAMA H, Nogami W, Sato Y, Yoshida H, et al
Characterization of CD44-positive Cancer Stem-like Cells in COLO 201 Cells.
Anticancer Res. 2020;40:169-176.
PubMed Abstract available

DORR NM, Bartels M, Morgul MH
Current Treatment of Colorectal Liver Metastasis as a Chronic Disease.
Anticancer Res. 2020;40:1-7.
PubMed Abstract available

December 2019

TANAKA H, Kawaguchi M, Shoda S, Miyoshi T, et al
Nuclear Accumulation of beta-Catenin in Cancer Stem Cell Radioresistance and Stemness in Human Colon Cancer.
Anticancer Res. 2019;39:6575-6583.
PubMed Abstract available

WU MH, Tzeng HE, Wu CN, Yueh TC, et al
Association of Matrix Metalloproteinase-9 rs3918242 Promoter Genotypes With Colorectal Cancer Risk.
Anticancer Res. 2019;39:6523-6529.
PubMed Abstract available

ZHU G, Zhao M, Han Q, Tan Y, et al
Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse Model.
Anticancer Res. 2019;39:6463-6470.
PubMed Abstract available

OGINO Y, Sato A, Kawano Y, Aoyama T, et al
Association of ABC Transporter With Resistance to FK866, a NAMPT Inhibitor, in Human Colorectal Cancer Cells.
Anticancer Res. 2019;39:6457-6462.
PubMed Abstract available

PETRELLI F, Ghidini M, Cabiddu M, Pezzica E, et al
Microsatellite Instability and Survival in Stage II Colorectal Cancer: A Systematic Review and Meta-analysis.
Anticancer Res. 2019;39:6431-6441.
PubMed Abstract available

DE FELICE F, Siniscalchi B, Bulzonetti N, Caiazzo R, et al
Tolerability of Oxaliplatin-based Neoadjuvant Chemoradiotherapy in Elderly Locally Advanced Rectal Cancer Patients: A Case-control Study of a Real-life Experience.
Anticancer Res. 2019;39:6957-6963.
PubMed Abstract available

FIORI E, Crocetti D, Lamazza A, DE Felice F, et al
Resection or Stenting in the Treatment of Symptomatic Advanced Metastatic Rectal Cancer: A Dilemma.
Anticancer Res. 2019;39:6781-6786.
PubMed Abstract available

CIZMARIKOVA M, Takac P, Spengler G, Kincses A, et al
New Chalcone Derivative Inhibits ABCB1 in Multidrug Resistant T-cell Lymphoma and Colon Adenocarcinoma Cells.
Anticancer Res. 2019;39:6499-6505.
PubMed Abstract available

SOHN M, Agha A, Trum S, Moser C, et al
Frequency of Polyps and Adenocarcinoma in Colon Interposition After Esophagectomy in Adulthood - A Systematic Review.
Anticancer Res. 2019;39:6419-6430.
PubMed Abstract available

November 2019

KAYANO H, Nomura E, Ueda Y, Kuramoto T, et al
Short- and Long-term Outcomes of 2-Step Stapled Intracorporeal Versus Extracorporeal Anastomosis in Laparoscopic Colectomy for Colon Cancer.
Anticancer Res. 2019;39:6393-6401.
PubMed Abstract available

KATAFYGIOTIS P, Sakellariou S, Chatziandreou I, Giannopoulou I, et al
Microsatellite Instability in Greek Colorectal Carcinoma Patients: Clinicopathological and Molecular Correlations.
Anticancer Res. 2019;39:6379-6387.
PubMed Abstract available

HORIUCHI T, Haruki K, Shiba H, Sakamoto T, et al
Assessment of Outcome of Hepatic Resection for Extremely Elderly Patients With a Hepatic Malignancy.
Anticancer Res. 2019;39:6325-6332.
PubMed Abstract available

HO ML, Kuo WK, Chu LJ, Yeh IH, et al
N-acetylgalactosamine-6-sulfatase (GALNS), Similar to Glycodelin, Is a Potential General Biomarker for Multiple Malignancies.
Anticancer Res. 2019;39:6317-6324.
PubMed Abstract available

PALAIOLOGOS P, Chrysikos D, Theocharis S, Kouraklis G, et al
The Prognostic Value of G1 Cyclins, p21 and Rb Protein in Patients With Colon Cancer.
Anticancer Res. 2019;39:6291-6297.
PubMed Abstract available

TREDER M, Janssen S, Schild SE, Rades D, et al
Results of Tri-Modality Therapy for Rectal Cancer in Elderly Patients.
Anticancer Res. 2019;39:6217-6222.
PubMed Abstract available

WU CC, Lai PY, Hsieh S, Cheng CC, et al
Suppression of Carnosine on Adhesion and Extravasation of Human Colorectal Cancer Cells.
Anticancer Res. 2019;39:6135-6144.
PubMed Abstract available

CHANDIMALI N, Sun HN, Kong LZ, Zhen X, et al
Shikonin-induced Apoptosis of Colon Cancer Cells Is Reduced by Peroxiredoxin V Expression.
Anticancer Res. 2019;39:6115-6123.
PubMed Abstract available

KIM HB, Lim HJ, Lee HJ, Park JH, et al
Evaluation and Clinical Significance of Jagged-1-activated Notch Signaling by APEX1 in Colorectal Cancer.
Anticancer Res. 2019;39:6097-6105.
PubMed Abstract available

VYCITAL O, Pitule P, Hosek P, Kriz T, et al
Expression of Serpin B9 as a Prognostic Factor of Colorectal Cancer.
Anticancer Res. 2019;39:6063-6066.
PubMed Abstract available

BUNDSCHERER AC, Ullrich V, Malsy M, Gruber MA, et al
Effects of Volatile Anesthetics on Proliferation and Viability of SW480 Colon Cancer Cells In Vitro.
Anticancer Res. 2019;39:6049-6055.
PubMed Abstract available

ZHU G, Zhao M, Han Q, Tan Y, et al
Combination of Trabectedin With Oxaliplatinum and 5-Fluorouracil Arrests a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse Model.
Anticancer Res. 2019;39:5999-6005.
PubMed Abstract available

LEHTOMAKI KI, Lahtinen LI, Rintanen N, Kuopio T, et al
Clonal Evolution of MEK/MAPK Pathway Activating Mutations in a Metastatic Colorectal Cancer Case.
Anticancer Res. 2019;39:5867-5877.
PubMed Abstract available

CUMBO M, Tomic B, Dunjic S, Jovanovic T, et al
Prothrombin 3'end Gene Variants in Patients With Sporadic Colon Adenocarcinoma.
Anticancer Res. 2019;39:6067-6071.
PubMed Abstract available

October 2019

NEKI K, Eto K, Kosuge M, Ohkuma M, et al
Identification of the Risk Factors for Recurrence of Stage III Colorectal Cancer.
Anticancer Res. 2019;39:5721-5724.
PubMed Abstract available

FIALA O, Ostasov P, Hosek P, Sorejs O, et al
The Predictive Role of Primary Tumour Sidedness in Metastatic Colorectal Cancer Treated With Targeted Agents.
Anticancer Res. 2019;39:5645-5652.
PubMed Abstract available

QIU Z, Andrijauskaite K, Morris J, Wargovich MJ, et al
Disruption of Epigenetic Silencing in Human Colon Cancer Cells Lines Utilizing a Novel Supercritical CO2 Extract of Neem Leaf (Azadirachta indica).
Anticancer Res. 2019;39:5473-5481.
PubMed Abstract available

UETA K, Matsuda T, Yamashita K, Hasegawa H, et al
Treatment Strategy for Rectal Cancer Patients With Inguinal Lymph Node Metastasis.
Anticancer Res. 2019;39:5767-5772.
PubMed Abstract available

SHIBUYA N, Matsuda T, Yamashita K, Hasegawa H, et al
Clinical Significance of Intraoperative Colonoscopy for Anastomotic Assessment in Rectal Cancer Surgery.
Anticancer Res. 2019;39:5761-5765.
PubMed Abstract available

September 2019

SHIBUTANI M, Nagahara H, Fukuoka T, Iseki Y, et al
Efficacy of Adjuvant Chemotherapy According to the Classification of Recurrence Risk Based on Systemic Inflammatory Markers in Patients With Liver Metastases of Colorectal Cancer.
Anticancer Res. 2019;39:5039-5045.
PubMed Abstract available

DIMBERG J, Shamoun L, Landerholm K, Andersson RE, et al
Genetic Variants of the IL2 Gene Related to Risk and Survival in Patients With Colorectal Cancer.
Anticancer Res. 2019;39:4933-4940.
PubMed Abstract available

SIGNORELLI C, Chilelli MG, Sperduti I, Giacinti S, et al
Correlation of Tumor Location to Clinical Outcomes in Colorectal Cancer: A Single-institution Retrospective Analysis.
Anticancer Res. 2019;39:4917-4924.
PubMed Abstract available

SEATON ME, Peters U, Johnson KC, Kooperberg C, et al
Effects of Colorectal Cancer Risk Factors on the Association Between Aspirin and Colorectal Cancer.
Anticancer Res. 2019;39:4877-4884.
PubMed Abstract available

YUN CW, Lee JH, Lee SH
Hypoxia-induced PGC-1alpha Regulates Mitochondrial Function and Tumorigenesis of Colorectal Cancer Cells.
Anticancer Res. 2019;39:4865-4876.
PubMed Abstract available

HA YJ, Tak KH, Kim SK, Kim CW, et al
Biological Characteristics and Clinical Significance of ITGB1 and RHOC in Patients With Recurrent Colorectal Cancer.
Anticancer Res. 2019;39:4853-4864.
PubMed Abstract available

KURAMOCHI H, Nakajima GO, Hayashi K, Araida T, et al
Amphiregulin/epiregulin mRNA Expression and Primary Tumor Location in Colorectal Cancer.
Anticancer Res. 2019;39:4729-4736.
PubMed Abstract available

OSHIRO H, Tome Y, Kiyuna T, Yoon SN, et al
Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model.
Anticancer Res. 2019;39:4667-4671.
PubMed Abstract available

OHARA T, Mori T
Antiproliferative Effects of Short-chain Fatty Acids on Human Colorectal Cancer Cells via Gene Expression Inhibition.
Anticancer Res. 2019;39:4659-4666.
PubMed Abstract available

FUKUOKA T, Maeda K, Nagahara H, Shibutani M, et al
Change in PMI During Neoadjuvant Therapy Is a Predictive Prognostic Marker in Rectal Cancer.
Anticancer Res. 2019;39:5157-5163.
PubMed Abstract available

ISKANDER O, Courtot L, Tabchouri N, Artus A, et al
Complete Pathological Response Following Radiochemotherapy for Locally Advanced Rectal Cancer: Short and Long-term Outcome.
Anticancer Res. 2019;39:5105-5113.
PubMed Abstract available

KOMORI K, Kinoshita T, Oshiro T, Ouchi A, et al
Surgical Strategy for Rectovaginal Fistula After Colorectal Anastomosis at a High-volume Cancer Center According to Image Type and Colonoscopy Findings.
Anticancer Res. 2019;39:5097-5103.
PubMed Abstract available

MORINE Y, Ikemoto T, Iwahashi S, Saito YU, et al
Clinical Impact of FOLFOXIRI Aiming for Conversion Surgery in Unresectable Multiple Colorectal Liver Metastasis.
Anticancer Res. 2019;39:5089-5096.
PubMed Abstract available

RUBIO CA, Schmidt PT
The Normal Epithelium of Crypts Accruing Below Nonpolypoid Adenomas Thrives With Relocated Proliferating Cell-domains and p53-Up-regulated Cells.
Anticancer Res. 2019;39:4965-4970.
PubMed Abstract available

LUCERI C, Femia AP, D'Ambrosio M, Caderni G, et al
High Sensitivity to Cholic Acid-induced Colonic Tumorigenesis Makes Female PIRC Rats (F344/NTac-Apc(am1137)) a Suitable Model for Studying CRC-promoting Agents.
Anticancer Res. 2019;39:4673-4679.
PubMed Abstract available

August 2019

HISAKA T, Ishikawa H, Sakai H, Kawahara R, et al
Sinusoidal Obstruction Syndrome and Postoperative Complications Resulting from Preoperative Chemotherapy for Colorectal Cancer Liver Metastasis.
Anticancer Res. 2019;39:4549-4554.
PubMed Abstract available

TAKIMOTO R, Kamigaki T, Okada S, Matsuda E, et al
Prognostic Factors for Colorectal Cancer Patients Treated With Combination of Immune-cell Therapy and First-line Chemotherapy: A Retrospective Study.
Anticancer Res. 2019;39:4525-4532.
PubMed Abstract available

ASHIZAWA N, Shimizu H, Sudo M, Furuya S, et al
Clinical Significance of NADPH Oxidase 5 in Human Colon Cancer.
Anticancer Res. 2019;39:4405-4410.
PubMed Abstract available

MATSUDA A, Yamada T, Matsumoto S, Sakurazawa N, et al
Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival After TAS-102 Treatment of Patients With Metastatic Colorectal Cancer.
Anticancer Res. 2019;39:4343-4350.
PubMed Abstract available

ITO Y, Kobuchi S, Takesada W, Takahashi C, et al
Assessment of Oxaliplatin-induced Chronic Neuropathy and Anticancer Efficacy Through Pharmacokinetic and Toxicodynamic Evaluation of a Rat Model of Colorectal Cancer.
Anticancer Res. 2019;39:4207-4213.
PubMed Abstract available

YOON SN, Park JH, Lwin TM, Miyake K, et al
Tumor-sealing Surgical Orthotopic Implantation of Human Colon Cancer in Nude Mice Induces Clinically-relevant Metastases Without Early Peritoneal Carcinomatosis.
Anticancer Res. 2019;39:4065-4071.
PubMed Abstract available

NAYERI M, Iskander O, Tabchouri N, Artus A, et al
Low Tie Compared to High Tie Vascular Ligation of the Inferior Mesenteric Artery in Rectal Cancer Surgery Decreases Postoperative Complications Without Affecting Overall Survival.
Anticancer Res. 2019;39:4363-4370.
PubMed Abstract available

RUBIO CA, Schmidt PT
Dissecting the Microscopic Anatomy of Colon Crypts in Non-dysplastic Sessile Serrated Polyps.
Anticancer Res. 2019;39:4259-4263.
PubMed Abstract available

July 2019

GIULIANI J, Bonetti A
The Onset of Grade >/=3 Neutropenia Is Associated With Longer Overall Survival in Metastatic Colorectal Cancer Patients Treated With Trifluridine/Tipiracil.
Anticancer Res. 2019;39:3967-3969.
PubMed Abstract available

CZUMAJ A, Zabielska J, Pakiet A, Mika A, et al
In Vivo Effectiveness of Orlistat in the Suppression of Human Colorectal Cancer Cell Proliferation.
Anticancer Res. 2019;39:3815-3822.
PubMed Abstract available

LIU Y, Kwon T, Kim JS, Chandimali N, et al
Peroxiredoxin V Reduces beta-Lapachone-induced Apoptosis of Colon Cancer Cells.
Anticancer Res. 2019;39:3677-3686.
PubMed Abstract available

KIM JY, Park G, Krishnan M, Ha E, et al
Selective Wnt/beta-catenin Small-molecule Inhibitor CWP232228 Impairs Tumor Growth of Colon Cancer.
Anticancer Res. 2019;39:3661-3667.
PubMed Abstract available

KOBUNAI T, Matsuoka K, Takechi T
ChIP-seq Analysis to Explore DNA Replication Profile in Trifluridine-treated Human Colorectal Cancer Cells In Vitro.
Anticancer Res. 2019;39:3565-3570.
PubMed Abstract available

PARK JH, Zhao M, Oshiro H, Miyake K, et al
Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively via Red Fluorescent Protein Labeled Stromal Cells.
Anticancer Res. 2019;39:3463-3467.
PubMed Abstract available

VUJIC J, Schollnast H, Marsoner K, Wienerroither V, et al
Marking Disappearing Colorectal Liver Metastases After Complete Response to Neoadjuvant Chemotherapy via CT - A Pilot Study.
Anticancer Res. 2019;39:3847-3854.
PubMed Abstract available

PATTAYIL L, Balakrishnan-Saraswathi HT
In Vitro Evaluation of Apoptotic Induction of Butyric Acid Derivatives in Colorectal Carcinoma Cells.
Anticancer Res. 2019;39:3795-3801.
PubMed Abstract available

June 2019

ETO S, Kawahara H, Matsumoto T, Hirabayashi T, et al
Preoperative Neutrophil-Lymphocyte Ratio Is a Predictor of Bowel Obstruction Due to Colorectal Cancer Growth.
Anticancer Res. 2019;39:3185-3189.
PubMed Abstract available

VIRGILIO E, Balducci G, Mercantini P, Ferri M, et al
Curative and Prophylactic Surgery of Young-onset Colorectal Cancer in Inherited Syndromes: A 15-Year Monocentric Retrospective Experience.
Anticancer Res. 2019;39:3131-3136.
PubMed Abstract available

MOKKARALA M, Noda C, Malone C, Ramaswamy R, et al
Comparison of Response and Outcomes of Drug-eluting Bead Chemoembolization (DEB-TACE) Versus Radioembolization (TARE) for Patients With Colorectal Cancer Liver Metastases.
Anticancer Res. 2019;39:3071-3077.
PubMed Abstract available

RYU S, Suwa K, Kitagawa T, Aizawa M, et al
Real-Time Fluorescence Vessel Navigation Using Indocyanine Green During Laparoscopic Colorectal Cancer Surgery.
Anticancer Res. 2019;39:3009-3013.
PubMed Abstract available

ISHIKAWA D, Takasu C, Kashihara H, Nishi M, et al
The Significance of MicroRNA-449a and Its Potential Target HDAC1 in Patients With Colorectal Cancer.
Anticancer Res. 2019;39:2855-2860.
PubMed Abstract available

WU MH, Hung YW, Gong CL, Chao CC, et al
Contribution of Caspase-8 Genotypes to Colorectal Cancer Risk in Taiwan.
Anticancer Res. 2019;39:2791-2797.
PubMed Abstract available

GZIL A, Szylberg L, Jaworski D, Dominiak J, et al
The Essential Role of DCLK1 in Pathogenesis, Diagnostic Procedures and Prognostic Stratification of Colorectal Cancer.
Anticancer Res. 2019;39:2689-2697.
PubMed Abstract available

JUNGINGER T, Goenner U, Trinh TT, Heintz A, et al
The Link Between Local Recurrence and Distant Metastases in Patients With Rectal Cancer.
Anticancer Res. 2019;39:3079-3088.
PubMed Abstract available

TAKEDA M, Kawahara H, Ogawa M, Suwa K, et al
Reevaluation of Preoperative Chemoradiotherapy for Clinical T3 Lower Rectal Cancer: A Multicenter Collaborative Retrospective Clinical Study.
Anticancer Res. 2019;39:3047-3052.
PubMed Abstract available

PALUMBO P, Usai S, Pansa A, Lucchese S, et al
Anastomotic Leakage in Rectal Surgery: Role of the Ghost Ileostomy.
Anticancer Res. 2019;39:2975-2983.
PubMed Abstract available

YOON G, Park JY, Kim HJ, Choi GS, et al
ARID3A Positivity Correlated With Favorable Prognosis in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy.
Anticancer Res. 2019;39:2845-2853.
PubMed Abstract available

TANIYAMA D, Taniyama K, Kuraoka K, Yamamoto H, et al
CD204-Positive Tumor-associated Macrophages Relate to Malignant Transformation of Colorectal Adenoma.
Anticancer Res. 2019;39:2767-2775.
PubMed Abstract available

May 2019

RADES D, Hansen HC, Janssen S, Schild SE, et al
Diagnosis-specific WBRT-30-CRC Score for Estimating Survival of Patients Irradiated for Brain Metastases from Colorectal Cancer.
Anticancer Res. 2019;39:2569-2574.
PubMed Abstract available

OGAWA H, Kaira K, Motegi Y, Yokobori T, et al
Role of Amino Acid Transporter Expression as a Prognostic Marker in Patients With Surgically Resected Colorectal Cancer.
Anticancer Res. 2019;39:2535-2543.
PubMed Abstract available

ANGELOU A, Antoniou E, Pikouli A, Wang J, et al
Platelet Depletion/Transfusion as a Lethal Factor in a Colitis-associated Cancer Mouse Model.
Anticancer Res. 2019;39:2443-2446.
PubMed Abstract available

MANTSO T, Vasileiadis S, Lampri E, Botaitis S, et al
Hyperthermia Suppresses Post - In Vitro Proliferation and Tumor Growth in Murine Malignant Melanoma and Colon Carcinoma.
Anticancer Res. 2019;39:2307-2315.
PubMed Abstract available

April 2019

RALLIS G, Koletsa T, Saridaki Z, Manousou K, et al
Association of Notch and Hedgehog Pathway Activation With Prognosis in Early-stage Colorectal Cancer.
Anticancer Res. 2019;39:2129-2138.
PubMed Abstract available

HAMADA K, Otsubo R, Takeshita H, Nonaka T, et al
Diagnosis of Lymph Node Metastasis in Colorectal Cancer by a Semi-dry Dot-blot Method.
Anticancer Res. 2019;39:2069-2076.
PubMed Abstract available

BENDARDAF R, Sharif-Askari FS, Sharif-Askari NS, Syrjanen K, et al
Cytoplasmic E-Cadherin Expression Is Associated With Higher Tumour Level of VEGFA, Lower Response Rate to Irinotecan-based Treatment and Poorer Prognosis in Patients With Metastatic Colorectal Cancer.
Anticancer Res. 2019;39:1953-1957.
PubMed Abstract available

ALAGARATNAM S, Yang SY, Loizidou M, Fuller B, et al
Mechano-growth Factor Expression in Colorectal Cancer Investigated With Fluorescent Gold Nanoparticles.
Anticancer Res. 2019;39:1705-1710.
PubMed Abstract available

FRANSGAARD T, Hallas J, Thygesen LC, Gogenur I, et al
Association of Statin Use and Oncological Outcomes After Neoadjuvant Radiotherapy in Patients With Rectal Cancer.
Anticancer Res. 2019;39:2177-2182.
PubMed Abstract available

PETRUCCIANI N, Carra MC, Martinez-Perez A, Vitali GC, et al
Comparison of Different Nodal Staging in Patients With Locally Advanced Mid-low Rectal Cancer After Long-term Neoadjuvant Chemoradiation Therapy.
Anticancer Res. 2019;39:2113-2120.
PubMed Abstract available

SADAHIRO S, Suzuki T, Tanaka A, Okada K, et al
Induction of CD3+ and FoxP3+ T Cells in Left-sided Colorectal Tumors After UFT/LV Chemotherapy.
Anticancer Res. 2019;39:1997-2005.
PubMed Abstract available

PINELLI A, Ferrario P, Trivulzio S
Preliminary Observation on the Cytotoxic Activity of New Chlorophyllin Derivative RCD on Human Tumour Cell Lines In Vitro.
Anticancer Res. 2019;39:1807-1812.
PubMed Abstract available

OSMAN J, Bellamkonda K, Liu Q, Andersson T, et al
The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer.
Anticancer Res. 2019;39:1719-1728.
PubMed Abstract available

March 2019

ARAKAWA K, Hata K, Nozawa H, Kawai K, et al
Molecular Subtypes Are Frequently Discordant Between Lesions in Patients With Synchronous Colorectal Cancer: Molecular Analysis of 59 Patients.
Anticancer Res. 2019;39:1425-1432.
PubMed Abstract available

NAGATA T, Fukuda KI, Tamai M, Taniguchi A, et al
Early Neuropathy Related to Oxaliplatin Treatment in Advanced and Recurrent Colorectal Cancer.
Anticancer Res. 2019;39:1347-1353.
PubMed Abstract available

YANO Y, Yoshimatsu K, Yokomizo H, Sagawa M, et al
Enhancement of the Marginal Area in Colorectal Cancer Liver Metastasis on Computed Tomography Correlates With Microvessel Density and Clinicopathological Factors.
Anticancer Res. 2019;39:1301-1308.
PubMed Abstract available

LI CC, Liang JA, Chung CY, Chen WT, et al
Effectiveness of Intensity-Modulated Radiotherapy for Rectal Cancer Patients Treated With Neoadjuvant Concurrent Chemoradiotherapy: A Population-based Propensity Score-matched Analysis.
Anticancer Res. 2019;39:1479-1484.
PubMed Abstract available

HANSEN HC, Janssen S, Thieme C, Perlov A, et al
Potential Impact of the Interval Between Imaging and Whole-brain Radiotherapy in Patients With Relatively Favorable Survival Prognoses.
Anticancer Res. 2019;39:1343-1346.
PubMed Abstract available

REZNICZEK GA, Grunwald C, Hilal Z, Scheich J, et al
ROBO1 Expression in Metastasizing Breast and Ovarian Cancer: SLIT2-induced Chemotaxis Requires Heparan Sulfates (Heparin).
Anticancer Res. 2019;39:1267-1273.
PubMed Abstract available

February 2019

YAMAMOTO M, Saito H, Uejima C, Tanio A, et al
Combination of Serum Albumin and Cholinesterase Levels as Prognostic Indicator in Patients ith Colorectal Cancer.
Anticancer Res. 2019;39:1085-1090.
PubMed Abstract available

SHIBUTANI M, Nagahara H, Fukuoka T, Iseki Y, et al
Prognostic Significance of the C-Reactive Protein-to-Albumin Ratio in Patients With Metastatic Colorectal Cancer Treated With Trifluridine/Thymidine Phosphorylase Inhibitor as Later-line Chemotherapy.
Anticancer Res. 2019;39:1051-1057.
PubMed Abstract available

KIMURA M, Usami E, Teramachi H, Yoshimura T, et al
Evaluation of Tolerability of Trifluridine/Tipiracil Combination Tablet in Patients With Advanced/Recurrent Colorectal Cancer.
Anticancer Res. 2019;39:1029-1034.
PubMed Abstract available

SMOLLE MA, Kashofer K, Riedl JM, Stotz M, et al
Genetic Analysis Using a Gene Panel in 87 Caucasian Patients With Colorectal Cancer: Own Results and Review of Literature.
Anticancer Res. 2019;39:847-852.
PubMed Abstract available

SRODA-POMIANEK K, Michalak K, Palko-Labuz A, Uryga A, et al
Simvastatin Strongly Augments Proapoptotic, Anti-inflammatory and Cytotoxic Activity of Oxicam Derivatives in Doxorubicin-resistant Colon Cancer Cells.
Anticancer Res. 2019;39:727-734.
PubMed Abstract available

BAE GE, DO SI, Kim K, Park JH, et al
Increased Sphingosine Kinase 1 Expression Predicts Distant Metastasis and Poor Outcome in Patients With Colorectal Cancer.
Anticancer Res. 2019;39:663-670.
PubMed Abstract available

LEE D, Matsuda T, Yamashita K, Hasegawa H, et al
Significance of Lateral Pelvic Lymph Node Size in Predicting Metastasis and Prognosis in Rectal Cancer.
Anticancer Res. 2019;39:993-998.
PubMed Abstract available

RUBIO CA, Schmidt PT
Crypts With Corrupted Shapes in Non-polypoid Adenomas.
Anticancer Res. 2019;39:833-838.
PubMed Abstract available

OZTOP S, Isik A, Guner G, Gurdal H, et al
Class III beta-tubulin Expression in Colorectal Neoplasms Is a Potential Predictive Biomarker for Paclitaxel Response.
Anticancer Res. 2019;39:655-662.
PubMed Abstract available

January 2019

KEARNEY MR, Chen EY, Vaccaro GM, Strother J, et al
A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer.
Anticancer Res. 2019;39:245-252.
PubMed Abstract available

SHIMIZU D, Masuda T, Sato K, Tsuruda Y, et al
CRMP5-associated GTPase (CRAG) Is a Candidate Driver Gene for Colorectal Cancer Carcinogenesis.
Anticancer Res. 2019;39:99-106.
PubMed Abstract available

KUDOU M, Arita T, Nakanishi M, Kuriu Y, et al
Essentiality of Imaging Diagnostic Criteria Specific to Rectal Neuroendocrine Tumors for Detecting Metastatic Lymph Nodes.
Anticancer Res. 2019;39:505-510.
PubMed Abstract available

GUIMARAES DP, Fregnani JH, Reis RM, Taveira LN, et al
Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.
Anticancer Res. 2019;39:261-269.
PubMed Abstract available

WAKUI M, Kawai K, Mizushima T, Nishime C, et al
Fatty Acid beta-Oxidation-dependent and -independent Responses and Tumor Aggressiveness Acquired Under Mild Hypoxia.
Anticancer Res. 2019;39:191-200.
PubMed Abstract available

MUTO Y, Furihata T, Kaneko M, Higuchi K, et al
Different Response Profiles of Gastrointestinal Cancer Cells to an L-Type Amino Acid Transporter Inhibitor, JPH203.
Anticancer Res. 2019;39:159-165.
PubMed Abstract available

GUDUR A, Shanmuganandamurthy D, Szep Z, Poggio JL, et al
An Update on the Current Role of High Resolution Anoscopy in Patients With Anal Dysplasia.
Anticancer Res. 2019;39:17-23.
PubMed Abstract available

December 2018

SHIBUYA N, Ishizuka M, Takagi K, Iwasaki Y, et al
Relationship Between Preoperative Erythrocyte Sedimentation Rate and Survival After Surgery in Patients with Colorectal Cancer.
Anticancer Res. 2018;38:6783-6788.
PubMed Abstract available

MATSUTANI S, Shibutani M, Maeda K, Nagahara H, et al
Tumor-infiltrating Immune Cells in H&E-stained Sections of Colorectal Cancer Tissue as a Reasonable Immunological Biomarker.
Anticancer Res. 2018;38:6721-6727.
PubMed Abstract available

KOH HK, Kim K, Jang WI, Song CH, et al
Radiation Therapy for Anal Squamous Cell Carcinoma: A Retrospective Multicenter Study.
Anticancer Res. 2018;38:6931-6938.
PubMed Abstract available

LEE JH, Song C, Kang SB, Lee HS, et al
Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
Anticancer Res. 2018;38:6905-6910.
PubMed Abstract available

KIM J, Ahn S, Kim K, Cho MS, et al
Prognostic Significance of Survivin Expression and Combined Analysis with Cancer Stem Cell and Epithelial-Mesenchymal Transition-related Markers in Patients with Rectal Cancer Undergoing Preoperative Chemoradiotherapy.
Anticancer Res. 2018;38:6881-6889.
PubMed Abstract available

RADES D, Vogelsang RP, Treder M, Janssen S, et al
A Matched-Pair Study Comparing Surgery Plus Neoadjuvant Radio-Chemotherapy and Surgery Alone for High Rectal Cancers.
Anticancer Res. 2018;38:6877-6880.
PubMed Abstract available

MORELLI C, Formica V, Pellicori S, Menghi A, et al
Chemotherapy in Patients with Hereditary Angioedema.
Anticancer Res. 2018;38:6801-6807.
PubMed Abstract available

November 2018

BENDARDAF R, Sharif-Askari FS, Sharif-Askari NS, Syrjanen K, et al
Patients with hMLH1 or/and hMSH2-deficient Metastatic Colorectal Cancer Are Associated with Reduced Levels of Vascular Endothelial Growth Factor-1 Expression and Higher Response Rate to Irinotecan-based Regimen.
Anticancer Res. 2018;38:6399-6404.
PubMed Abstract available

MASUDA T, Margonis GA, Andreatos N, Wang J, et al
Combined Hepatic Resection and Radio-frequency Ablation for Patients with Colorectal Cancer Liver Metastasis: A Viable Option for Patients with a Large Number of Tumors.
Anticancer Res. 2018;38:6353-6360.
PubMed Abstract available

ENKHBAT T, Nishi M, Yoshikawa K, Jun H, et al
Epigallocatechin-3-gallate Enhances Radiation Sensitivity in Colorectal Cancer Cells Through Nrf2 Activation and Autophagy.
Anticancer Res. 2018;38:6247-6252.
PubMed Abstract available

DA SILVA MACHADO F, Munari FM, Scariot FJ, Echeverrigaray S, et al
Piperlongumine Induces Apoptosis in Colorectal Cancer HCT 116 Cells Independent of Bax, p21 and p53 Status.
Anticancer Res. 2018;38:6231-6236.
PubMed Abstract available

SUEHIRO Y, Takemoto Y, Nishimoto A, Ueno K, et al
Dclk1 Inhibition Cancels 5-FU-induced Cell-cycle Arrest and Decreases Cell Survival in Colorectal Cancer.
Anticancer Res. 2018;38:6225-6230.
PubMed Abstract available

SEMAAN C, Neilson KA, Brown B, Molloy MP, et al
Pharmacological Inhibition of Casein Kinase 2 Enhances the Effectiveness of PI3K Inhibition in Colon Cancer Cells.
Anticancer Res. 2018;38:6195-6200.
PubMed Abstract available

NAKURTE I, Jekabsons K, Rembergs R, Zandberga E, et al
Colorectal Cancer Cell Line SW480 and SW620 Released Extravascular Vesicles: Focus on Hypoxia-induced Surface Proteome Changes.
Anticancer Res. 2018;38:6133-6138.
PubMed Abstract available

WANG B, Ogata H, Takishima Y, Miyamoto S, et al
A Novel Combination Therapy for Human Oxaliplatin-resistant Colorectal Cancer Using Oxaliplatin and Coxsackievirus A11.
Anticancer Res. 2018;38:6121-6126.
PubMed Abstract available

MASUISHI T, Taniguchi H, Eto T, Komori A, et al
Morphologic Response and Tumor Shrinkage as Early Predictive Markers in Unresectable Colorectal Liver Metastases.
Anticancer Res. 2018;38:6501-6506.
PubMed Abstract available

PALKOVICS A, Vereczkei A, Kalmar KN, Fincsur A, et al
The Issue of Survival After Colorectal Liver Metastasis Surgery: Parenchyma Sparing vs. Radicality.
Anticancer Res. 2018;38:6431-6438.
PubMed Abstract available

October 2018

KAMIZA AB, Wang WC, You JF, Tang R, et al
EGFR, SMAD7, and TGFBR2 Polymorphisms Are Associated with Colorectal Cancer in Patients with Lynch Syndrome.
Anticancer Res. 2018;38:5983-5990.
PubMed Abstract available

ARAKAWA K, Hata K, Nozawa H, Kawai K, et al
Prognostic Significance and Clinicopathological Features of Synchronous Colorectal Cancer.
Anticancer Res. 2018;38:5889-5895.
PubMed Abstract available

KIM JN, Kim TH, Yoon JH, Cho SG, et al
Kisspeptin Inhibits Colorectal Cancer Cell Invasiveness by Activating PKR and PP2A.
Anticancer Res. 2018;38:5791-5798.
PubMed Abstract available

SINGH B, Singh G, Pourgholami M, Alzahrani N, et al
Long-term Survival and Propensity Score Matched Outcomes of Bilateral vs. Unilateral Diaphragm Interventions in Cytoreductive Surgery plus Intra-peritoneal Chemotherapy.
Anticancer Res. 2018;38:5917-5921.
PubMed Abstract available

MURATA H, Okamoto M, Takahashi T, Motegi M, et al
SUVmax-based Parameters of FDG-PET/CT Reliably Predict Pathologic Complete Response After Preoperative Hyperthermo-chemoradiotherapy in Rectal Cancer.
Anticancer Res. 2018;38:5909-5916.
PubMed Abstract available

DE CESARE M
High Efficacy of Intravenous Gimatecan on Human Tumor Xenografts.
Anticancer Res. 2018;38:5783-5790.
PubMed Abstract available

AKAMINE T, Morodomi Y, Harada Y, Teraishi K, et al
miR-3148 Is a Novel Onco-microRNA that Potentiates Tumor Growth In Vivo.
Anticancer Res. 2018;38:5693-5701.
PubMed Abstract available

September 2018

JORDAN F, Grundmann N, Schenkirsch G, Markl B, et al
Impact of Primary Tumor Localization on the Efficacy of Bevacizumab in Metastatic Colorectal Cancer.
Anticancer Res. 2018;38:5539-5546.
PubMed Abstract available

KAWAHARA H, Yoshida S, Tohyama Y, Yanagisawa S, et al
Serum Carcinoembryonic Antigen Levels Before the First Curative Hepatectomy for Metastatic Colorectal Cancer Is a Predictor of Recurrence.
Anticancer Res. 2018;38:5351-5355.
PubMed Abstract available

ENDZELINS E, Abols A, Buss A, Zandberga E, et al
Extracellular Vesicles Derived from Hypoxic Colorectal Cancer Cells Confer Metastatic Phenotype to Non-metastatic Cancer Cells.
Anticancer Res. 2018;38:5139-5147.
PubMed Abstract available

LEA MA, Kim H, desBORDES C
Effects of Biguanides on Growth and Glycolysis of Bladder and Colon Cancer Cells.
Anticancer Res. 2018;38:5003-5011.
PubMed Abstract available

TRESKA V, Fichtl J, Ludvik J, Bruha J, et al
Portal Vein Embolization (PVE) Versus PVE with Haematopoietic Stem Cell Application in Patients with Primarily Non-resectable Colorectal Liver Metastases.
Anticancer Res. 2018;38:5531-5537.
PubMed Abstract available

PARK CK, Kim HS
Clinicopathological Characteristics of Ovarian Metastasis from Colorectal and Pancreatobiliary Carcinomas Mimicking Primary Ovarian Mucinous Tumor.
Anticancer Res. 2018;38:5465-5473.
PubMed Abstract available

HEINZE C, Omari J, Othmer M, Hass P, et al
Image-guided Interstitial Brachytherapy in the Management of Metastasized Anal Squamous Cell Carcinoma.
Anticancer Res. 2018;38:5401-5407.
PubMed Abstract available

TREDER M, Janssen S, Hollander NH, Schild SE, et al
Role of Neoadjuvant Radio-chemotherapy for the Treatment of High Rectal Cancer.
Anticancer Res. 2018;38:5371-5377.
PubMed Abstract available

RUBIO CA, Schmidt PT
Are Non-dysplastic Crypts with Corrupted Shapes the Initial Recordable Histological Event in the Development of Sporadic Conventional Adenomas?
Anticancer Res. 2018;38:5315-5320.
PubMed Abstract available

August 2018

DAITOKU N, Miyamoto Y, Tokunaga R, Sakamoto Y, et al
Controlling Nutritional Status (CONUT) Score Is a Prognostic Marker in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy.
Anticancer Res. 2018;38:4883-4888.
PubMed Abstract available

ARAKAWA K, Hata K, Kawai K, Tanaka T, et al
Predictors for High Microsatellite Instability in Patients with Colorectal Cancer Fulfilling the Revised Bethesda Guidelines.
Anticancer Res. 2018;38:4871-4876.
PubMed Abstract available

HIRAYAMA K, Sudoh M, Shimizu H, Furuya S, et al
Clinical Impact of Histological Heterogeneity in the Metastatic Lymph Nodes of Patients with Colorectal Cancer.
Anticancer Res. 2018;38:4797-4803.
PubMed Abstract available

KARLBERG M, Stenstedt K, Hallstrom M, Ragnhammar P, et al
Tumor Budding Versus Mismatch Repair Status in Colorectal Cancer - An Exploratory Analysis.
Anticancer Res. 2018;38:4713-4721.
PubMed Abstract available

SIM JJ, Park MH, Baek JH, Lee H, et al
Investigation into Enhancing Capecitabine Efficacy in Colorectal Cancer by Inhibiting Focal Adhesion Kinase Signaling.
Anticancer Res. 2018;38:4667-4676.
PubMed Abstract available

LIU W, Zhang D, Tan SA, Liu X, et al
Sigmoid Colon Adenocarcinoma with Isolated Loss of PMS2 Presenting in a Patient with Synchronous Prostate Cancer with Intact MMR: Diagnosis and Analysis of the Family Pedigree.
Anticancer Res. 2018;38:4847-4852.
PubMed Abstract available

LEE YM, Yeo MK, Seong IO, Kim KH, et al
Nuclear Expression of CD133 Is Associated with Good Prognosis in Patients with Colorectal Adenocarcinoma.
Anticancer Res. 2018;38:4819-4826.
PubMed Abstract available

MIYAKITA H, Sadahiro S, Kamei Y, Ogimi T, et al
Chemoradiotherapy-induced Changes in Mucinous Components in Rectal Cancer Tissue: Evaluation on High Iron Diamine-alcian Blue and Mucin 1 Staining.
Anticancer Res. 2018;38:4783-4787.
PubMed Abstract available

TUTINO V, DE Nunzio V, Tafaro A, Bianco G, et al
Cannabinoid Receptor-1 Up-regulation in Azoxymethane (AOM)-treated Mice After Dietary Treatment with Quercetin.
Anticancer Res. 2018;38:4485-4491.
PubMed Abstract available

NAKAMURA M, Suetsugu A, Hasegawa K, Satake T, et al
Color-coded Imaging Distinguishes Cancer Cells, Stromal Cells, and Recombinant Cancer-stromal Cells in the Tumor Microenvironment During Metastasis.
Anticancer Res. 2018;38:4417-4423.
PubMed Abstract available

July 2018

YOSHIDA Y, Sakamoto R, Kajitani R, Munechika T, et al
Biweekly Administration of TAS-102 for Neutropenia Prevention in Patients with Colorectal Cancer.
Anticancer Res. 2018;38:4367-4373.
PubMed Abstract available

LUO H, Nishi K, Ishikura S, Swain A, et al
Growth Suppression of Human Colorectal Cancer Cells with Mutated KRAS by 3-Deaza-cytarabine in 3D Floating Culture.
Anticancer Res. 2018;38:4247-4256.
PubMed Abstract available

YUN CW, Kim S, Lee JH, Lee SH, et al
Melatonin Promotes Apoptosis of Colorectal Cancer Cells via Superoxide-mediated ER Stress by Inhibiting Cellular Prion Protein Expression.
Anticancer Res. 2018;38:3951-3960.
PubMed Abstract available

CHABOWSKI M, Nowak A, Grzegrzolka J, Piotrowska A, et al
Comparison of Microvessel Density Using Nestin and CD34 in Colorectal Cancer.
Anticancer Res. 2018;38:3889-3895.
PubMed Abstract available

RUBIO CA, Schmidt PT
Severe Defects in the Macrophage Barrier to Gut Microflora in Inflammatory Bowel Disease and Colon Cancer.
Anticancer Res. 2018;38:3811-3815.
PubMed Abstract available

MAEDA K, Shibutani M, Otani H, Fukuoka T, et al
Neoadjuvant Radiotherapy with Capecitabine Plus Bevacizumab for Locally Advanced Lower Rectal Cancer: Results of a Single-institute Phase II Study.
Anticancer Res. 2018;38:4193-4197.
PubMed Abstract available

VYCITAL O, Dubova M, Palek R, Hosek P, et al
The Impact of Immune Interaction on the Metastatic Infiltration of Colorectal Carcinoma to Lymph Nodes.
Anticancer Res. 2018;38:4159-4167.
PubMed Abstract available

TUPY R, Mirka H, Mracek J, Priban V, et al
Tumor-related Perfusion Changes in White Matter Adjacent to Brain Tumors: Pharmacodynamic Analysis of Dynamic 3T Magnetic Resonance Imaging.
Anticancer Res. 2018;38:4149-4152.
PubMed Abstract available

KIM S, Park SG, Song YJ, Park JK, et al
Analysis of Anticancer Activity and Chemical Sensitization Effects of Dendropanax morbifera and Commersonia bartramia Extracts.
Anticancer Res. 2018;38:3853-3861.
PubMed Abstract available

June 2018

SAWAZAKI S, Numata M, Morita J, Maezawa Y, et al
Safety of Laparoscopic Surgery for Colorectal Cancer in Patients with Severe Comorbidities.
Anticancer Res. 2018;38:3767-3772.
PubMed Abstract available

VENALAINEN MK, Roine AN, Hakkinen MR, Vepsalainen JJ, et al
Altered Polyamine Profiles in Colorectal Cancer.
Anticancer Res. 2018;38:3601-3607.
PubMed Abstract available

ENKHBAT T, Nishi M, Takasu C, Yoshikawa K, et al
Programmed Cell Death Ligand 1 Expression Is an Independent Prognostic Factor in Colorectal Cancer.
Anticancer Res. 2018;38:3367-3373.
PubMed Abstract available

OKUNO T, Kawai K, Hata K, Murono K, et al
SN-38 Acts as a Radiosensitizer for Colorectal Cancer by Inhibiting the Radiation-induced Up-regulation of HIF-1alpha.
Anticancer Res. 2018;38:3323-3331.
PubMed Abstract available

ANGELOU A, Andreatos N, Antoniou E, Zacharioudaki A, et al
A Novel Modification of the AOM/DSS Model for Inducing Intestinal Adenomas in Mice.
Anticancer Res. 2018;38:3467-3470.
PubMed Abstract available

LING G, Lamprecht S, Shubinsky G, Osyntsov L, et al
Mycophenolate Mofetil Alone and in Combination with Tacrolimus Inhibits the Proliferation of HT-29 Human Colonic Adenocarcinoma Cell Line and Might Interfere with Colonic Tumorigenesis.
Anticancer Res. 2018;38:3333-3339.
PubMed Abstract available

May 2018

RADES D, Dziggel L, Blanck O, Gebauer N, et al
A Score to Identify Patients with Brain Metastases from Colorectal Cancer Who May Benefit from Whole-brain Radiotherapy in Addition to Stereotactic Radiosurgery/Radiotherapy.
Anticancer Res. 2018;38:3111-3114.
PubMed Abstract available

TEI M, Otsuka M, Suzuki Y, Kishi K, et al
Safety and Feasibility of Single-port Surgery for Colon Cancer in Octogenarians.
Anticancer Res. 2018;38:2967-2972.
PubMed Abstract available

PATANKAR M, Vayrynen S, Tuomisto A, Makinen M, et al
Micropapillary Structures in Colorectal Cancer: An Anoikis-resistant Subpopulation.
Anticancer Res. 2018;38:2915-2921.
PubMed Abstract available

DESHWAR A, Margonis GA, Andreatos N, Barbon C, et al
Double KRAS and BRAF Mutations in Surgically Treated Colorectal Cancer Liver Metastases: An International, Multi-institutional Case Series.
Anticancer Res. 2018;38:2891-2895.
PubMed Abstract available

CACEV T, Zapletal E, Musani V, Rako I, et al
Analysis of MSH2 Loss of Heterozygosity, Expression, and IVS10+12G>A Polymorphism in Sporadic Colon Cancer.
Anticancer Res. 2018;38:2841-2848.
PubMed Abstract available

TUTINO V, Defrancesco ML, Tolomeo M, DE Nunzio V, et al
The Expression of Riboflavin Transporters in Human Colorectal Cancer.
Anticancer Res. 2018;38:2659-2667.
PubMed Abstract available

CLOUSTON HW, Rees PA, Lamb R, Duff SE, et al
Effect of Tissue Factor on Colorectal Cancer Stem Cells.
Anticancer Res. 2018;38:2635-2642.
PubMed Abstract available

ALFONSO PG, Podesta MC, Martin AM, Codeisido MB, et al
Chemotherapy Plus Bevacizumab as Neoadjuvant or Conversion Treatment in Patients with Colorectal Liver Metastases.
Anticancer Res. 2018;38:3069-3077.
PubMed Abstract available

CUSHMAN TR, Venigalla S, Brooks ED, Lin C, et al
Utilization of Neoadjuvant Intensity-modulated Radiation Therapy for Rectal Cancer in the United States.
Anticancer Res. 2018;38:2923-2927.
PubMed Abstract available

JOO JW, Kim HS, Do SI, Sung JY, et al
Expression of Zinc Finger and BTB Domain-containing 7A in Colorectal Carcinoma.
Anticancer Res. 2018;38:2787-2792.
PubMed Abstract available

April 2018

KAWAHARA H, Mouri T, Ishida K, Matsumoto N, et al
Usefulness of TAS-102 as Third-line Chemotherapy for Metastatic Colorectal Cancer.
Anticancer Res. 2018;38:2419-2422.
PubMed Abstract available

ISEKI Y, Shibutani M, Maeda K, Nagahara H, et al
MicroRNA-96 Promotes Tumor Invasion in Colorectal Cancer via RECK.
Anticancer Res. 2018;38:2031-2035.
PubMed Abstract available

LIN KM, Yang MD, Tsai CW, Chang WS, et al
The Role of MTHFR Genotype in Colorectal Cancer Susceptibility in Taiwan.
Anticancer Res. 2018;38:2001-2006.
PubMed Abstract available

LEE JH, Yoon YM, Han YS, Yun CW, et al
Melatonin Promotes Apoptosis of Oxaliplatin-resistant Colorectal Cancer Cells Through Inhibition of Cellular Prion Protein.
Anticancer Res. 2018;38:1993-2000.
PubMed Abstract available

WANG W, Li Y, Chen Y, Chen H, et al
Ethanolic Extract of Traditional Chinese Medicine (TCM) Gamboge Inhibits Colon Cancer via the Wnt/Beta-Catenin Signaling Pathway in an Orthotopic Mouse Model.
Anticancer Res. 2018;38:1917-1925.
PubMed Abstract available

RUBIO CA, Schmidt PT
Morphological Classification of Corrupted Colonic Crypts in Ulcerative Colitis.
Anticancer Res. 2018;38:2253-2259.
PubMed Abstract available

SIDERIS M, Donaldson AN, Hanrahan J, Grunwald M, et al
Radiotherapy May Offer a Recurrence and Survival Benefit in Rectal Cancers Treated Surgically with Transanal Endoscopic Microsurgery: A Systematic Review and Meta-analysis.
Anticancer Res. 2018;38:1879-1895.
PubMed Abstract available

March 2018

ETO K, Kosuge M, Ohkuma M, Noaki R, et al
Defunctioning Ileostomy Is a Key Risk Factor for Small Bowel Obstruction After Colorectal Cancer Resection.
Anticancer Res. 2018;38:1789-1795.
PubMed Abstract available

FURUKE H, Komatsu S, Ikeda J, Tanaka S, et al
Self-expandable Metallic Stents Contribute to Reducing Perioperative Complications in Colorectal Cancer Patients with Acute Obstruction.
Anticancer Res. 2018;38:1749-1753.
PubMed Abstract available

SUENAGA M, Akiyoshi T, Shinozaki E, Fujimoto Y, et al
A Feasibility Study of Capecitabine and Oxaliplatin for Patients with Stage II/III Colon Cancer -ACTOR Study.
Anticancer Res. 2018;38:1741-1747.
PubMed Abstract available

OKUGAWA Y, Shirai Y, Toiyama Y, Saigusa S, et al
Clinical Burden of Modified Glasgow Prognostic Scale in Colorectal Cancer.
Anticancer Res. 2018;38:1599-1610.
PubMed Abstract available

CHEN Y, Lee CH, Tseng BY, Tsai YH, et al
AZD8055 Exerts Antitumor Effects on Colon Cancer Cells by Inhibiting mTOR and Cell-cycle Progression.
Anticancer Res. 2018;38:1445-1454.
PubMed Abstract available

BABA T, Kokuryo T, Yamaguchi J, Yokoyama Y, et al
Pre-exposure to Fluorouracil Increased Trifluridine Incorporation and Enhanced its Anti-tumor Effect for Colorectal Cancer.
Anticancer Res. 2018;38:1427-1434.
PubMed Abstract available

NA K, Sung JY, Kim HS
Clinicopathological Characteristics of High-grade Squamous Intraepithelial Lesions Involving Condyloma Acuminatum.
Anticancer Res. 2018;38:1767-1774.
PubMed Abstract available

YOSHIKAWA K, Shimada M, Higashijima J, Nakao T, et al
Ki-67 and Survivin as Predictive Factors for Rectal Cancer Treated with Preoperative Chemoradiotherapy.
Anticancer Res. 2018;38:1735-1739.
PubMed Abstract available

KERR D, Laber D, Visweshwar N, Jaglal M, et al
Case Report: CEA Elevation Can Be a Marker of Increased Inflammation During Treatment with Oxaliplatin.
Anticancer Res. 2018;38:1711-1713.
PubMed Abstract available

LACZMANSKA I, Sasiadek M, Laczmanski L
The Comparison Between Molecular Tumour Profiling in Microdissected and Surgical Tissue Samples.
Anticancer Res. 2018;38:1415-1418.
PubMed Abstract available

February 2018

SHINAGAWA T, Hata K, Morikawa T, Takiyama H, et al
Protrusion on the Depressed Surface of Non-polypoid T1 Colorectal Cancer Is Associated with Venous Invasion.
Anticancer Res. 2018;38:993-1002.
PubMed Abstract available

NUMATA M, Sawazaki S, Morita J, Maezawa Y, et al
Comparison of Laparoscopic and Open Surgery for Colorectal Cancer in Patients with Severe Comorbidities.
Anticancer Res. 2018;38:963-967.
PubMed Abstract available

KANG S, Oh SC, Min BW, Lee DH, et al
Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem Cells.
Anticancer Res. 2018;38:787-794.
PubMed Abstract available

OSADA S, Gotoh A, Yokoi R, Tsuchiya H, et al
Effective Timing of Surgical Resection of Colorectal Cancer Liver Metastases During Chemotherapy.
Anticancer Res. 2018;38:737-743.
PubMed Abstract available

HAUSMANN D, Liu J, Budjan J, Reichert M, et al
Image Quality Assessment of 2D versus 3D T2WI and Evaluation of Ultra-high b-Value (b=2,000 mm/s(2)) DWI for Response Assessment in Rectal Cancer.
Anticancer Res. 2018;38:969-978.
PubMed Abstract available

RUBIO CA, DE Petris G, Puppa G
Gut-associated Lymphoid Tissue (GALT) Carcinoma in Ulcerative Colitis.
Anticancer Res. 2018;38:919-921.
PubMed Abstract available

BUNDSCHERER AC, Malsy M, Gruber MA, Graf BM, et al
Acetaminophen and Metamizole Induce Apoptosis in HT 29 and SW 480 Colon Carcinoma Cell Lines In Vitro.
Anticancer Res. 2018;38:745-751.
PubMed Abstract available

JUNG YY, Sung JY, Kim JY, Kim HS, et al
Down-regulation of B-Cell Translocation Gene 1 by Promoter Methylation in Colorectal Carcinoma.
Anticancer Res. 2018;38:691-697.
PubMed Abstract available

LUNDBERG IV, Wikberg ML, Ljuslinder I, Li X, et al
MicroRNA Expression in KRAS- and BRAF-mutated Colorectal Cancers.
Anticancer Res. 2018;38:677-683.
PubMed Abstract available

CEAUSU AR, Ciolofan A, Cimpean AM, Magheti A, et al
The Mesenchymal-Epithelial and Epithelial-Mesenchymal Cellular Plasticity of Liver Metastases with Digestive Origin.
Anticancer Res. 2018;38:811-816.
PubMed Abstract available

January 2018

KATSUKI T, Nakayama Y, Akiyama M, Sawatsubashi Y, et al
Prognostic Significance of Mitochondrial Transcription Factor A Expression in Patients with Right- or Left-sided Colorectal Cancer.
Anticancer Res. 2018;38:569-575.
PubMed Abstract available

TAKAHASHI H, Haraguchi N, Nishimura J, Hata T, et al
The Severity of Anastomotic Leakage May Negatively Impact the Long-term Prognosis of Colorectal Cancer.
Anticancer Res. 2018;38:533-539.
PubMed Abstract available

MIYAMOTO Y, Oki E, Emi Y, Tokunaga S, et al
Low Visceral Fat Content Is a Negative Predictive Marker for Bevacizumab in Metastatic Colorectal Cancer.
Anticancer Res. 2018;38:491-499.
PubMed Abstract available

SHAMOUN L, Kolodziej B, Andersson RE, Dimberg J, et al
Protein Expression and Genetic Variation of IL32 and Association with Colorectal Cancer in Swedish Patients.
Anticancer Res. 2018;38:321-328.
PubMed Abstract available

JO YK, Park NY, Shin JH, Jo DS, et al
Up-regulation of UVRAG by HDAC1 Inhibition Attenuates 5FU-induced Cell Death in HCT116 Colorectal Cancer Cells.
Anticancer Res. 2018;38:271-277.
PubMed Abstract available

YANG G, Qiu J, Wang D, Tao Y, et al
Traditional Chinese Medicine Curcumin Sensitizes Human Colon Cancer to Radiation by Altering the Expression of DNA Repair-related Genes.
Anticancer Res. 2018;38:131-136.
PubMed Abstract available

MURONO K, Kawai K, Hata K, Emoto S, et al
Regimens of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer.
Anticancer Res. 2018;38:15-22.
PubMed Abstract available

SPELT L, Sasor A, Ansari D, Hilmersson KS, et al
The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases.
Anticancer Res. 2018;38:313-320.
PubMed Abstract available

GLEI M, Fischer S, Lamberty J, Ludwig D, et al
Chemopreventive Potential of In Vitro Fermented Raw and Roasted Hazelnuts in LT97 Colon Adenoma Cells.
Anticancer Res. 2018;38:83-93.
PubMed Abstract available

December 2017

LIANG YH, Shao YY, Chen HM, Cheng AL, et al
Irinotecan and Oxaliplatin Might Provide Equal Benefit as Adjuvant Chemotherapy for Patients with Resectable Synchronous Colon Cancer and Liver-confined Metastases: A Nationwide Database Study.
Anticancer Res. 2017;37:7095-7104.
PubMed Abstract available

GKEKAS I, Novotny J, Pecen L, Strigard K, et al
Microsatellite Instability as a Prognostic Factor in Stage II Colon Cancer Patients, a Meta-Analysis of Published Literature.
Anticancer Res. 2017;37:6563-6574.
PubMed Abstract available

YAMAMOTO S, Kanai T, Osumi K, Yo K, et al
Anastomotic Leakage Using Linear Stapling Device with Pre-attached Bioabsorbable Polyglycolic Acid Felt After Laparoscopic Anterior Resection.
Anticancer Res. 2017;37:7083-7086.
PubMed Abstract available

MIYATA T, Beppu T, Higashi T, Nakagawa S, et al
A Glissonean Approach with Individual Isolation During Right Hemi-Hepatectomy After Portal Vein Embolization.
Anticancer Res. 2017;37:7069-7071.
PubMed Abstract available

RUBIO CA
Updated Histologic Classification of Adenomas and Carcinomas in the Colon of Carcinogen-treated Sprague-Dawley Rats.
Anticancer Res. 2017;37:6667-6670.
PubMed Abstract available

November 2017

KAJITANI T, Makiyama A, Arita S, Shimokawa H, et al
Anti-Epidermal Growth Factor Receptor Antibody Readministration in Chemorefractory Metastatic Colorectal Cancer.
Anticancer Res. 2017;37:6459-6468.
PubMed Abstract available

MERCIER J, Voutsadakis IA
A Systematic Review and Meta-analysis of Retrospective Series of Regorafenib for Treatment of Metastatic Colorectal Cancer.
Anticancer Res. 2017;37:5925-5934.
PubMed Abstract available

CIRIMBEI C, Rotaru V, Chitoran E, Pavaleanu O, et al
Immediate and Long-term Results of Radiofrequency Ablation for Colorectal Liver Metastases.
Anticancer Res. 2017;37:6489-6494.
PubMed Abstract available

October 2017

TAKIYAMA A, Tanaka T, Yamamoto Y, Hata K, et al
Microsatellite Status of Primary Colorectal Cancer Predicts the Incidence of Postoperative Colorectal Neoplasms.
Anticancer Res. 2017;37:5785-5790.
PubMed Abstract available

BAKALOVA R, Zhelev Z, Shibata S, Nikolova B, et al
Impressive Suppression of Colon Cancer Growth by Triple Combination SN38/EF24/Melatonin: "Oncogenic" Versus "Onco-Suppressive" Reactive Oxygen Species.
Anticancer Res. 2017;37:5449-5458.
PubMed Abstract available

TANASE T, Hamada C, Yoshino T, Ohtsu A, et al
A Proposal for Progression-Free Survival Assessment in Patients with Early Progressive Cancer.
Anticancer Res. 2017;37:5851-5855.
PubMed Abstract available

IDE S, Toiyama Y, Okugawa Y, Oki S, et al
Clinical Significance of C-Reactive Protein-to-Albumin Ratio with Rectal Cancer Patient Undergoing Chemoradiotherapy Followed by Surgery.
Anticancer Res. 2017;37:5797-5804.
PubMed Abstract available

KAWAHARA H, Akiba T, Yanaga K
Transanal Assisted Resection with Closure of Anal Canal for Lower Rectal Diseases.
Anticancer Res. 2017;37:5767-5769.
PubMed Abstract available

TOKUNAGA T, Nishi M, Higashijima J, Yoshikawa K, et al
Feasibility of Transanal Local Excision Following Chemoradiation for Lower Rectal Cancer.
Anticancer Res. 2017;37:5617-5622.
PubMed Abstract available

SUNG JY, Na K, Kim HS
Down-regulation of Inositol Polyphosphate 4-Phosphatase Type II Expression in Colorectal Carcinoma.
Anticancer Res. 2017;37:5525-5531.
PubMed Abstract available

IKEMURA M, Hashida T
Effect of Hyperglycemia on Antitumor Activity and Survival in Tumor-bearing Mice Receiving Oxaliplatin and Fluorouracil.
Anticancer Res. 2017;37:5463-5468.
PubMed Abstract available

September 2017

KANEKO M, Nozawa H, Emoto S, Murono K, et al
Neoadjuvant Imatinib Therapy Followed by Intersphincteric Resection for Low Rectal Gastrointestinal Stromal Tumors.
Anticancer Res. 2017;37:5155-5160.
PubMed Abstract available

ANNEDE P, Darreon J, Benkemouche A, Valdenaire S, et al
Flattening Filter Free vs. Flattened Beams for Lung Stereotactic Body Radiation Therapy.
Anticancer Res. 2017;37:5133-5139.
PubMed Abstract available

NONAKA T, Fukuda A, Maekawa K, Nagayoshi S, et al
Clinical and Oncological Outcomes of Laparoscopic Lateral Pelvic Lymph Node Dissection in Advanced Lower Rectal Cancer: Single-institution Experience.
Anticancer Res. 2017;37:5095-5100.
PubMed Abstract available

CARINI F, Mazzola M, Rappa F, Jurjus A, et al
Colorectal Carcinogenesis: Role of Oxidative Stress and Antioxidants.
Anticancer Res. 2017;37:4759-4766.
PubMed Abstract available

BAR JK, Lis-Nawara A, Grelewski P, Noga L, et al
The Association Between HSP90/topoisomerase I Immunophenotype and the Clinical Features of Colorectal Cancers in Respect to KRAS Gene Status.
Anticancer Res. 2017;37:4953-4960.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: